Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation

Authors:

Abstract
No abstract available
Funding Information
  • Georg-August-Universität Göttingen

This publication has 14 references indexed in Scilit: